Objective: To understand the mode of action of the currently most investigated new drugs in renal cell carcinoma (RCC) and ultimately to analyze what should be the role of the urologist in this new therapeutic era.
Your session will expire in 8 hours requiring you to log in each day to view content.
FEBRUARY 11, 2012